Tempest Therapeutics Inc (NQ: TPST )
1.440
-0.110
(-7.10%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
All News about Tempest Therapeutics Inc
![](https://cdn.benzinga.com/files/images/story/2024/08/15/TPST.png?width=1200&height=800&fit=crop)
Via Benzinga
Exposures
Product Safety
![](https://ml.globenewswire.com/media/6ddb04fb-e5ac-416b-b90b-b4cbf51dc538/small/blue-logo-stacked-jpg.jpg)
![](https://investorplace.com/wp-content/uploads/2023/10/tpst1600.png)
![](https://ml.globenewswire.com/media/6ddb04fb-e5ac-416b-b90b-b4cbf51dc538/small/blue-logo-stacked-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/07/05/Coins-Money-Increase-To-Profit-For-Conce.jpeg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
![](https://cdn.benzinga.com/files/images/story/2024/06/20/xrdDAFl-HSvCpE2-j6755793051000407071-t23_0.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2024/06/20/Gold-Yuannotes-China.jpeg?width=1200&height=800&fit=crop)
Gold Rises 1%; Accenture Shares Surge After Q3 Results
June 20, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2024/06/20/Cancer-Image-by-PDPics-from-Pixabay-.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2020/02/medicine-iv-drip.jpg)
![](https://investorplace.com/wp-content/uploads/2019/10/mergers-acquisitions.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/06/20/movers-image_11.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2023/10/tpst1600.png)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://ml.globenewswire.com/media/6ddb04fb-e5ac-416b-b90b-b4cbf51dc538/small/blue-logo-stacked-jpg.jpg)
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-pre-market.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://ml.globenewswire.com/media/6ddb04fb-e5ac-416b-b90b-b4cbf51dc538/small/blue-logo-stacked-jpg.jpg)
![](https://ml.globenewswire.com/media/6ddb04fb-e5ac-416b-b90b-b4cbf51dc538/small/blue-logo-stacked-jpg.jpg)
![](https://mms.businesswire.com/media/20240531560531/en/2146855/5/GPM_Logo_Color_RGB.jpg)
![](https://ml.globenewswire.com/media/6ddb04fb-e5ac-416b-b90b-b4cbf51dc538/small/blue-logo-stacked-jpg.jpg)
From Tempest Therapeutics
Via GlobeNewswire
![](https://investorplace.com/wp-content/uploads/2023/10/tpst1600.png)
![](https://ml.globenewswire.com/media/6ddb04fb-e5ac-416b-b90b-b4cbf51dc538/small/blue-logo-stacked-jpg.jpg)
![](https://ml.globenewswire.com/media/6ddb04fb-e5ac-416b-b90b-b4cbf51dc538/small/blue-logo-stacked-jpg.jpg)
From Tempest Therapeutics
Via GlobeNewswire
![](https://ml.globenewswire.com/media/6ddb04fb-e5ac-416b-b90b-b4cbf51dc538/small/blue-logo-stacked-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/04/05/image13_0.jpg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/6ddb04fb-e5ac-416b-b90b-b4cbf51dc538/small/blue-logo-stacked-jpg.jpg)
![](https://investorplace.com/wp-content/uploads/2023/10/tpst1600.png)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.